3D model

3D-Bioprinted Cancer Model to Test Anticancer Drugs

April 19, 2019

Researchers from both the University of Minnesota College of Science and Engineering and Medical School have created a new, dynamic 3D bioprinted tumor model that will help researchers screen anticancer drugs and study the spread of cancer.

The new model should help a current major pitfall of translating drugs from the lab bench to a viable treatment due to the differences of a 2D petri dish versus the 3D human body.

"I think our model has the key components to push the boundaries of in vitro cancer research,” said co-senior author Angela Panoskaltsis-Mortari, PhD, Department of Pediatrics.

The results of the studypublished in Advanced Materials, found that the 3D-bioprinted model shows drugs take more time to kill fewer cells than previous studies have shown, however, the results likely show a more accurate representation.

Other News

University of Minnesota sign
CTSI awareded NIH funding to find better, faster ways to bring scientific advances to real-world use.
A group of people sitting around a table in a classroom.
The Community Teacher program connects health professions students with patient volunteers.
Students working together
Case competitions provide a team-based experience for our learners.